However, some studies report contrasting findings, such as reduced FABP5 expression levels in pancreatic cancer [24], and evidence suggesting that FABP5 overexpression in liver cancer is associated with prolonged OS and disease‐free survival (DFS) [25]. This evidence concerns the gene FABP5 and liver cancer.